SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

71,909.70 -570.59
( -0.79%)

Global Indices

Nasdaq

50,952.25 25.20
(0.05%)

Dow Jones

7,687.74 15.20
(0.20%)

Hang Seng

68,256.51 -700.21
(-1.02%)

Nikkei 225

10,432.22 -173.78
(-1.64%)

Forex

USD-INR

95.92 -0.05
(-0.05%)

EUR-INR

108.79 -0.10
(-0.09%)

GBP-INR

127.19 0.21
(0.17%)

JPY-INR

0.61 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Colinz Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

531210

INE923C01011

39.8678099

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

36.39

18.52

EPS(TTM)

Face Value()

Div & Yield %

2.02

Back

Ramkrishna Forgings consolidated net profit rises 297.63% in the June 2026 quarter

Jul 24,2026

Net profit of Ramkrishna Forgings rose 297.63% to Rs 46.88 crore in the quarter ended June 2026 as against Rs 11.79 crore during the previous quarter ended June 2025. Sales rose 19.84% to Rs 1216.67 crore in the quarter ended June 2026 as against Rs 1015.26 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1216.67	1015.26	20
OPM %	17.91	13.98	-
PBDT	164.17	96.99	69
PBT	64.73	17.32	274
NP	46.88	11.79	298

71,909.70 -570.59 ( -0.79%)

50,952.25 25.20 (0.05%)

7,687.74 15.20 (0.20%)

68,256.51 -700.21 (-1.02%)

10,432.22 -173.78 (-1.64%)

95.92 -0.05 (-0.05%)

108.79 -0.10 (-0.09%)

127.19 0.21 (0.17%)

0.61 0.00 (0.14%)